| Register
spacer spacer spacer
spacer
Pharmaceutical Drug and Medical Device Litigation

If you are interested in discussing a potential case, please contact us by e-mail via this Web site or call  1-973-696-7900.

Although medications can provide positive health and lifestyle changes, medications carry their own health risks. Both healthcare providers and patients need and deserve to be properly informed of these risks.

Pharmaceutical Drugs That Are Potentially Defective

Products can change from life giving to life taking when pharmaceutical and biological companies:

  • fail to properly study their products both pre- and post-FDA approval,
  • fail to properly analyze study results,
  • fail to properly monitor, report and/or analyze adverse events,
  • fail to properly market products, or
  • fail to properly educate healthcare providers and patients about benefits and risks of these products.

 

Proving such negligence requires experience, creativity and adequate resources. But the end result can change the way the industry practices, and most importantly can save lives.

An example of our pharmaceutical drug litigation experience is the representation of many cases involving serious health problems stemming from the use of the diet drugs commonly known as Fen-Phen. The combination of some diet drugs has led to heart valve damage, stroke and heart attacks. We also represent clients that have been victims of medical prescription error.

Our lawyers and staff represent individuals who were injured through the use of pharmaceutical drugs and provide our clients with up-to-date information about the drug and their legal options.

Medical Devices That Are Potentially Defective

Medical devices and implants are used to treat injury and disease. Yet patients rarely see a device’s information, read the warning labels, or research the device and its history before receiving treatment. With medical breakthroughs on the rise, it is important for companies to perform adequate testing and regulate a device before placing it on the market. Jon L. Gelman represents individuals who have suffered serious injury or death as a result of a defective medical device including Dalkon Shield and Breast Inplants.

With advancements in medicine, there has been an increased use of medical devices in the treatment of injuries and diseases. Despite medical breakthroughs, medical devices are often inadequately tested and regulated and then rushed to market by companies in a hurry to make a profit. Over the past several years, several medical devices have been pulled from the market because they caused serious injury or death to thousands of Americans.

Our Experience with Drug and Medical Device Lawsuits

We have the necessary experience, creativity and resources to litigate pharmaceutical drug cases and seek legal recourse on behalf of those injured by pharmaceutical drugs.

Jon L. Gelman represents individuals harmed by pharmaceutical drugs in claims against drug manufacturers, which typically fall into the following categories:

  • Strict liability claims focus on the drug and whether it has a defect that makes it unreasonably unsafe.
  • Negligence claims are based on whether the manufacturer has acted with reasonable care in developing, manufacturing and marketing the drug or product.
spacer
spacer spacer spacer
spacer spacer spacer
spacer
Treatise
space
space
spacer
spacer spacer spacer
spacer spacer spacer
spacer
Pharmacetical Drug Articles
Tekturna Study Terminated: Potential risk of serious side effects linked to blood pressure drug

In December 2011, Tekturna® manufacturer Novartis announced its decision to terminate the clinical ALTITUDE study of the blood pressure drug based on the recommendation of the independent Data Monitoring Committee (DMC) overseeing the clinical trial study. 

Pradaxa Side Effects: Stroke drug linked to serious and even fatal injuries

 Following a November 2011 warning issued by the European Medicines Agency (EMA), the Food and Drug Administration (FDA) decided to reevaluate the safety of Pradaxa®. 

Jon Gelman Named in Best Lawyers in America 2012

Jon Gelman has been named again to Best Lawyers in America®. This recognition has been bestowed upon him for almost 2 decades. 

Selection to Best Lawyers® is based on an exhaustive and rigorous peer-review survey comprising more than 2.5 million confidential evaluations by the top attorneys in the country. Because no fee or purchase is required, being listed in Best Lawyers is considered a singular honor. The annual, advertisement-free publication has been described in The American Lawyer as “the most respected referral list of attorneys in practice.”
 

Transvaginal Surgical Mesh Products Problems Raise Call for Recall

Jon L. Gelman is accepting cases in which recipients of transvaginal mesh/sling products have suffered from complications. Transvaginal meshes are implanted through surgery. According to the FDA, contributing factors to complications potentially include the patient’s health, mesh material, the size and shape of the mesh, surgical procedures and estrogen levels.

Jon L. Gelman on the Super Lawyers List for 2011

Jon L. Gelman has been named to the 2010 edition of New Jersey Super Lawyers. Each year, only 5 percent of the lawyers in the state receive this honor.

FDA Votes to Restrict Avandia Due to Risks

Jon L Gelman is investigating cases involving individuals who have suffered a heart attack, ischemic stroke or other cardiac condition while taking Avandia for diabetes.

Infant Tylenol, Motrin, Zyrtec and Benadryl Reaction Claims

Jon Gelman is investigating cases involving infant drugs manufactured by pharmaceutical company McNeil Consumer Healthcare including include certain liquid infant’s and children’s Tylenol®, Motrin®, Zyrtec®, and Benadryl® products.

Paxil Adverse Reaction Claims

Jon Gelman is investigating cases involving Paxil users who have a child who suffered birth malformations after being exposed to Paxil within any trimester of pregnancy. Paxil and Paxil CR® are antidepressants manufactured by the pharmaceutical company GlaxoSmithKline.

FDA Requires Botox® Maker to Notify of Potential Adverse Effects

 FDA requires manufacturer of Botox® to post warning on its product of potential adverse reactions.

Medtronic Paradigm® Quick-set® Infusion Sets Recalled Due to Potential Injuries

On July 10, 2009, Medtronic, Inc., announced a defect in the Paradigm® Quick-Set® Infusion Sets. The company identified a potentially high rate of failure of the system to function properly and deliver medication to the patient in an accurate manner through the pump.

spacer
spacer spacer spacer
Copyright 2012 by Jon Gelman, LLC - Attorney at Law   |  Privacy Statement  |  Terms Of Use